Connection

Swapan Ray to Animals

This is a "connection" page, showing publications Swapan Ray has written about Animals.
Connection Strength

1.291
  1. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines. Neurochem Res. 2020 Oct; 45(10):2336-2351.
    View in: PubMed
    Score: 0.053
  2. Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells. Apoptosis. 2020 04; 25(3-4):217-232.
    View in: PubMed
    Score: 0.052
  3. Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis. Int J Mol Sci. 2019 Oct 11; 20(20).
    View in: PubMed
    Score: 0.050
  4. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy. Neurochem Res. 2019 Jul; 44(7):1715-1725.
    View in: PubMed
    Score: 0.049
  5. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016 04 01; 27(3):271-81.
    View in: PubMed
    Score: 0.039
  6. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Apoptosis. 2016 Mar; 21(3):312-28.
    View in: PubMed
    Score: 0.039
  7. Experimental Procedures for Demonstration of MicroRNA Mediated Enhancement of Functional Neuroprotective Effects of Estrogen Receptor Agonists. Methods Mol Biol. 2016; 1366:359-372.
    View in: PubMed
    Score: 0.039
  8. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. J Alzheimers Dis. 2016; 50(2):335-52.
    View in: PubMed
    Score: 0.039
  9. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 2014 Oct; 109:22-31.
    View in: PubMed
    Score: 0.035
  10. Combination of LC3 shRNA plasmid transfection and genistein treatment inhibited autophagy and increased apoptosis in malignant neuroblastoma in cell culture and animal models. PLoS One. 2013; 8(10):e78958.
    View in: PubMed
    Score: 0.033
  11. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Exp Cell Res. 2013 Jun 10; 319(10):1575-85.
    View in: PubMed
    Score: 0.032
  12. Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma. Anticancer Agents Med Chem. 2011 May 01; 11(4):398-407.
    View in: PubMed
    Score: 0.028
  13. Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics. 2011 Apr; 8(2):180-6.
    View in: PubMed
    Score: 0.028
  14. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol. 2010 Nov; 12(11):1088-101.
    View in: PubMed
    Score: 0.027
  15. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res. 2009 Dec 01; 15(23):7186-95.
    View in: PubMed
    Score: 0.025
  16. Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth. J Cell Mol Med. 2009 Oct; 13(10):4205-18.
    View in: PubMed
    Score: 0.025
  17. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells. Brain Res. 2009 May 01; 1268:142-153.
    View in: PubMed
    Score: 0.024
  18. Proteases and phospholipases in CNS disorders. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):225-6.
    View in: PubMed
    Score: 0.023
  19. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):270-7.
    View in: PubMed
    Score: 0.023
  20. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer. 2008 Feb 01; 112(3):596-607.
    View in: PubMed
    Score: 0.022
  21. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis. 2007 Nov; 12(11):2077-87.
    View in: PubMed
    Score: 0.022
  22. Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor. Neurochem Res. 2007 Dec; 32(12):2235-42.
    View in: PubMed
    Score: 0.022
  23. Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res. 2007 Dec; 32(12):2167-83.
    View in: PubMed
    Score: 0.022
  24. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem Res. 2007 Dec; 32(12):2210-6.
    View in: PubMed
    Score: 0.022
  25. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res. 2007 Dec; 32(12):2203-9.
    View in: PubMed
    Score: 0.022
  26. Methylprednisolone and indomethacin inhibit oxidative stress mediated apoptosis in rat C6 glioblastoma cells. Neurochem Res. 2007 Nov; 32(11):1849-56.
    View in: PubMed
    Score: 0.021
  27. Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res. 2006 Apr 21; 1084(1):146-57.
    View in: PubMed
    Score: 0.020
  28. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. Curr Med Chem. 2006; 13(28):3425-40.
    View in: PubMed
    Score: 0.019
  29. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res. 2005 Aug 15; 81(4):551-62.
    View in: PubMed
    Score: 0.019
  30. Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat. 2003 Oct; 26(2):119-24.
    View in: PubMed
    Score: 0.017
  31. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 2003 May; 42(2):169-85.
    View in: PubMed
    Score: 0.016
  32. Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. Int J Mol Sci. 2022 Feb 21; 23(4).
    View in: PubMed
    Score: 0.015
  33. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021 Jan; 17(1):1-382.
    View in: PubMed
    Score: 0.014
  34. Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Neurotox Res. 2020 Oct; 38(3):640-649.
    View in: PubMed
    Score: 0.013
  35. Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation. Neurochem Res. 2017 Oct; 42(10):2755-2768.
    View in: PubMed
    Score: 0.011
  36. Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
    View in: PubMed
    Score: 0.010
  37. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. J Neurochem. 2016 10; 139(2):270-284.
    View in: PubMed
    Score: 0.010
  38. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats. J Neurochem. 2016 05; 137(4):604-17.
    View in: PubMed
    Score: 0.010
  39. Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats. J Neurochem. 2016 Mar; 136(5):1064-73.
    View in: PubMed
    Score: 0.010
  40. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222.
    View in: PubMed
    Score: 0.010
  41. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014 Jan 15; 22(2):673-83.
    View in: PubMed
    Score: 0.008
  42. Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013 Aug; 114(1):43-50.
    View in: PubMed
    Score: 0.008
  43. Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
    View in: PubMed
    Score: 0.008
  44. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J Neurochem. 2013 Jan; 124(1):133-46.
    View in: PubMed
    Score: 0.008
  45. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms. J Pineal Res. 2013 Jan; 54(1):58-68.
    View in: PubMed
    Score: 0.008
  46. Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats. J Neurosci Res. 2012 Nov; 90(11):2134-45.
    View in: PubMed
    Score: 0.008
  47. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.007
  48. Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review. J Neurosci Res. 2012 May; 90(5):913-24.
    View in: PubMed
    Score: 0.007
  49. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012 Jan 04; 87(1):10-20.
    View in: PubMed
    Score: 0.007
  50. Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis. Invest Ophthalmol Vis Sci. 2011 Jul 01; 52(7):4935-41.
    View in: PubMed
    Score: 0.007
  51. Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies. J Neurochem. 2011 Aug; 118(3):326-38.
    View in: PubMed
    Score: 0.007
  52. Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines. Neurochem Int. 2011 Aug; 59(2):175-84.
    View in: PubMed
    Score: 0.007
  53. Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res. 2011 Oct; 36(10):1809-16.
    View in: PubMed
    Score: 0.007
  54. Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cells. J Neurosci Res. 2011 Apr; 89(4):536-43.
    View in: PubMed
    Score: 0.007
  55. Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death. Neurochem Res. 2011 Sep; 36(9):1587-93.
    View in: PubMed
    Score: 0.007
  56. Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons. Neurochem Res. 2010 Dec; 35(12):2175-83.
    View in: PubMed
    Score: 0.007
  57. Estrogen receptor agonists and estrogen attenuate TNF-a-induced apoptosis in VSC4.1 motoneurons. J Endocrinol. 2011 Feb; 208(2):171-82.
    View in: PubMed
    Score: 0.007
  58. Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. J Neurosci Res. 2010 Aug 15; 88(11):2398-408.
    View in: PubMed
    Score: 0.007
  59. Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation. Exp Neurol. 2010 Oct; 225(2):430-5.
    View in: PubMed
    Score: 0.007
  60. Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J Neurosci Res. 2010 Jun; 88(8):1738-50.
    View in: PubMed
    Score: 0.007
  61. Physiological low dose of estrogen-protected neurons in experimental spinal cord injury. Ann N Y Acad Sci. 2010 Jun; 1199:86-9.
    View in: PubMed
    Score: 0.007
  62. Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats. Ann N Y Acad Sci. 2010 Jun; 1199:90-4.
    View in: PubMed
    Score: 0.007
  63. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res. 2010 Mar; 48(2):157-69.
    View in: PubMed
    Score: 0.006
  64. Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma. Brain Res. 2009 Dec 08; 1301:163-70.
    View in: PubMed
    Score: 0.006
  65. Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells. J Neurochem. 2009 Sep; 110(6):1895-907.
    View in: PubMed
    Score: 0.006
  66. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res. 2009 Sep; 47(2):134-142.
    View in: PubMed
    Score: 0.006
  67. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels. Brain Res. 2009 Jun 18; 1276:159-70.
    View in: PubMed
    Score: 0.006
  68. Time-dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis. J Neurosci Res. 2008 Oct; 86(13):2992-3001.
    View in: PubMed
    Score: 0.006
  69. Extranigral neurodegeneration in Parkinson's disease. Ann N Y Acad Sci. 2008 Oct; 1139:331-6.
    View in: PubMed
    Score: 0.006
  70. Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):305-12.
    View in: PubMed
    Score: 0.006
  71. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):313-20.
    View in: PubMed
    Score: 0.006
  72. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res. 2008 Sep; 45(2):117-24.
    View in: PubMed
    Score: 0.006
  73. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res. 2008 May; 44(4):348-57.
    View in: PubMed
    Score: 0.006
  74. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP. J Neurochem. 2008 Mar; 104(5):1309-20.
    View in: PubMed
    Score: 0.006
  75. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res. 2006 Oct; 84(5):1064-75.
    View in: PubMed
    Score: 0.005
  76. Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci. 2006 Aug; 1074:349-56.
    View in: PubMed
    Score: 0.005
  77. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 2005 Oct 15; 82(2):283-93.
    View in: PubMed
    Score: 0.005
  78. A role for calpain in optic neuritis. Ann N Y Acad Sci. 2005 Aug; 1053:48-54.
    View in: PubMed
    Score: 0.005
  79. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res. 2005 Jul 01; 81(1):53-61.
    View in: PubMed
    Score: 0.005
  80. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res. 2004 Nov; 29(11):2007-14.
    View in: PubMed
    Score: 0.004
  81. Higher calpastatin levels correlate with resistance to calpain-mediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury. J Neurotrauma. 2004 Sep; 21(9):1240-54.
    View in: PubMed
    Score: 0.004
  82. 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. J Neurosci Res. 2004 Jun 01; 76(5):688-96.
    View in: PubMed
    Score: 0.004
  83. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Res. 2004 May 01; 1006(2):150-6.
    View in: PubMed
    Score: 0.004
  84. Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res. 2003 Jul 01; 73(1):95-104.
    View in: PubMed
    Score: 0.004
  85. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res. 2003 May 09; 971(2):178-88.
    View in: PubMed
    Score: 0.004
  86. Estrogen as a neuroprotective agent in the treatment of spinal cord injury. Ann N Y Acad Sci. 2003 May; 993:125-33; discussion 159-60.
    View in: PubMed
    Score: 0.004
  87. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Ann N Y Acad Sci. 2002 Jun; 965:274-80.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.